NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

OpenAI's Executive Bench Undergoes Major Overhaul Amid Leadership Changes

Fidji Simo, CEO of AGI development at OpenAI, has announced that she will be taking a significant medical leave due to a worsening neuroimmune condition, according to a recent Bloomberg report. Simo, who was hired in May last year and oversees the company's product and business, was diagnosed with Postural Orthostatic Tachycardia Syndrome (POTS) in 2019.

Simo's decision to go on leave comes as the company is gearing up for a possible initial public offering (IPO) and has just raised $122 billion in funding at an $852 billion valuation. Despite her absence, Simo expressed confidence in OpenAI's leadership team, stating that the company is "in great hands" and that she has an "excellent leadership team that's ready to step up."

During Simo's absence, OpenAI President Greg Brockman will oversee the product department. In addition to this leadership change, Simo announced a few more executive-level changes at OpenAI. Brad Lightcap, the longtime COO of OpenAI, will now lead special projects and report directly to Chief Executive Officer Sam Altman. The company's chief revenue officer, Denise Dresser, will take over most of his responsibilities.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Meanwhile, Chief Marketing Officer Kate Rouch will be stepping down from her role to focus on cancer recovery. Rouch was diagnosed with late-stage breast cancer around a year and a half ago and has been working at OpenAI while undergoing treatment. Simo stated that Rouch will return to a more narrowly-scoped role when she deems fit healthwise.

ExecutiveCurrent RoleNew Role
Fidji SimoCEO of AGI developmentMedical leave
Greg BrockmanPresidentOverseeing product department
Brad LightcapCOOLeading special projects
Denise DresserChief revenue officerTaking over COO responsibilities
Kate RouchChief Marketing OfficerStepping down for cancer recovery

OpenAI's leadership shakeup comes amid a pivotal time for the company, with a strong focus on advancing frontier research, growing its global user base of nearly 1 billion users, and powering enterprise use cases. The company's spokesperson stated that OpenAI is "well-positioned to keep executing with continuity and momentum."

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.